Cargando…
Neutralization of Schwann Cell-Secreted VEGF Is Protective to In Vitro and In Vivo Experimental Diabetic Neuropathy
The pathogenetic role of vascular endothelial growth factor (VEGF) in long-term retinal and kidney complications of diabetes has been demonstrated. Conversely, little is known in diabetic neuropathy. We examined the modulation of VEGF pathway at mRNA and protein level on dorsal root ganglion (DRG) n...
Autores principales: | Taiana, Michela M., Lombardi, Raffaella, Porretta-Serapiglia, Carla, Ciusani, Emilio, Oggioni, Norberto, Sassone, Jenny, Bianchi, Roberto, Lauria, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182455/ https://www.ncbi.nlm.nih.gov/pubmed/25268360 http://dx.doi.org/10.1371/journal.pone.0108403 |
Ejemplares similares
-
Schwann cell necroptosis in diabetic neuropathy
por: Belavgeni, Alexia, et al.
Publicado: (2022) -
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
por: Canta, Annalisa, et al.
Publicado: (2022) -
In vitro modulation of Schwann cell behavior by VEGF and PDGF in an inflammatory environment
por: Basu, Souptik, et al.
Publicado: (2022) -
The Effect of Schwann Cells/Schwann Cell-Like Cells on Cell Therapy for Peripheral Neuropathy
por: Wang, Qian, et al.
Publicado: (2022) -
Author Correction: In vitro modulation of Schwann cell behavior by VEGF and PDGF in an inflammatory environment
por: Basu, Souptik, et al.
Publicado: (2022)